| For: | Liang C, Wu HM, Yu WM, Chen W. Research status on immunotherapy trials of gastric cancer. World J Clin Cases 2021; 9(21): 5782-5793 [PMID: 34368297 DOI: 10.12998/wjcc.v9.i21.5782] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v9/i21/5782.htm |
| Number | Citing Articles |
| 1 |
Min Fu, Yongbiao Huang, Xiaohong Peng, Xiaoyu Li, Na Luo, Wenjun Zhu, Feng Yang, Ziqi Chen, Shengling Ma, Yuanyuan Zhang, Qianxia Li, Guangyuan Hu. Development of Tumor Mutation Burden-Related Prognostic Model and Novel Biomarker Identification in Stomach Adenocarcinoma. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.790920
|
| 2 |
Mohini Vig, Shweta Dubey. . International Review of Cell and Molecular Biology 2025; doi: 10.1016/bs.ircmb.2024.12.014
|
| 3 |
Fei Jiang, Xiaowei Chen, Yan Shen, Xiaobing Shen. Identification and Validation of an m6A Modification of JAK-STAT Signaling Pathway–Related Prognostic Prediction Model in Gastric Cancer. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.891744
|
| 4 |
Li Xiang, Chuan Lan, Luca Falzone. Significance of a Tumor Mutation Burden Gene Signature with Prognosis and Immune Feature of Gastric Cancer Patients. International Journal of Genomics 2022; 2022 doi: 10.1155/2022/7684606
|
| 5 |
Ziyi Zhou, Biao Chen, Kaiyue Zheng, Dewen Wan, Peng Kuang. Aurora A‐Mediated Exosomal Secretion of miR‐644a Promotes T‐Lymphocyte Apoptosis Through the NOXA/p4E‐BP1/MCL‐1 Pathway. Clinical and Experimental Pharmacology and Physiology 2026; 53(6) doi: 10.1111/1440-1681.70132
|
| 6 |
Zhongting Lu, Anqi Wang, Xiangnv Meng, Peng He, Tao Li, Jing Chen. Global research trends and emerging hotspots of immune checkpoint inhibitors in gastric cancer from 2015 to 2025. Discover Oncology 2026; 17(1) doi: 10.1007/s12672-026-05710-w
|
| 7 |
Safia Samir, Hend Okasha Ahmed, Tarek M. Diab, Amr Mostafa, Hesham A. Elmeligy, Amira Kamel, Heba Khalil. Rate of Epstein-Barr Virus in Gastric Adenocarcinoma in Egyptian Patients in View of the WHO Classification and Correlation with p16 Immunoreactivity. Open Access Macedonian Journal of Medical Sciences 2022; 10(A) doi: 10.3889/oamjms.2022.9700
|
| 8 |
Youngdong Choi, Hong Kyu Lee, Dohee Ahn, Min-Woo Nam, Ryeo-Eun Go, Kyung-Chul Choi. Genetically engineered neural stem cells expressing cytosine deaminase and interferon-beta enhanced T cell-mediated antitumor immunity against gastric cancer in a humanized mouse model. Life Sciences 2023; 328 doi: 10.1016/j.lfs.2023.121866
|
| 9 |
Ning Li, Zhi Li, Qiang Fu, Bin Zhang, Jian Zhang, Xiang-Bin Wan, Chao-Min Lu, Jin-Bang Wang, Wen-Ying Deng, Yi-Jie Ma, Liang-Yu Bie, Meng-Yu Wang, Jing Li, Qing-Xin Xia, Chen Wei, Su-Xia Luo. Efficacy and safety of neoadjuvant sintilimab in combination with FLOT chemotherapy in patients with HER2-negative locally advanced gastric or gastroesophageal junction adenocarcinoma: an investigator-initiated, single-arm, open-label, phase II study. International Journal of Surgery 2024; 110(4) doi: 10.1097/JS9.0000000000001119
|